Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population

Canadian Journal of Cardiology

Volumn 15, Issue 4, 1999, Pages 428-433

  Connelly, Philip W ^a,e   Petrasovits, Andres ^b   Stachenko, Sylvie ^b   MacLean, David R ^c   Little, J Alick ^d   Chockalingam, Arun ^b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b HEALTH CANADA   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e J Alick Little Lipid Res Laboratory   (Canada)

Author keywords

Cholesterol; Coronary disease; Lipids; Lipoproteins; Population health; Risk factors; Triglycerides

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CANADA; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; CORONARY RISK; DIABETES MELLITUS; FEMALE; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CANADA; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; PREVALENCE; RANDOM ALLOCATION; RISK FACTORS; SEX DISTRIBUTION; SMOKING; TRIGLYCERIDES;

EID: 0032937019     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Prevention of coronary heart disease - scientific background and new clinical guidelines. Nutr Metab Cardiovasc Dis 1992;2:113-56.
2. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993;269:3015-23.
3. Assmann G, Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Munster study. Am J Cardiol 1992;70:733-7.
4. Austin MA, Hokanson JE. Epidemiology of triglycerides, small dense low-density lipoprotein, and lipoprotein(a) as risk factors for coronary heart disease. Med Clin North Am 1994;78:99-115.
5. Karpe F, Bard JM, Steiner G, Carlson LA, Fruchart JC, Hamsten A. HDLs and alimentary lipemia. Studies in men with previous myocardial infarction at a young age. Arterioscler Thromb 1993;13:11-22.
6. Patsch W, Gotto AM Jr. High-density lipoprotein cholesterol, plasma triglyceride, and coronary heart disease: pathophysiology and management. Adv Pharmacol 1995;32:375-426.
7. Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev 1995;75:473-86.
8. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996;334:374-81.
9. Despres JP, Lamarche B, Mauriege P, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996;334:952-7.
10. MacLean DR, Petrasovits A, Nargundkar M, et al. Canadian heart health surveys: a profile of cardiovascular risk. Survey methods and data analysis. Canadian Heart Health Surveys Research Group. Can Med Assoc J 1992;146:1969-74.
11. Connelly PW, MacLean DR, Horlick L, O'Connor B, Petrasovits A, Little JA. Plasma lipids and lipoproteins and the prevalence of risk for coronary heart disease in Canadian adults. Canadian Heart Health Surveys Research Group. Can Med Assoc J 1992;146:1977-87.
12. MacLean DR, Petrasovits A, Connelly PW, O'Connor B, Little JA. Plasma lipids and lipoprotein reference values and the prevalence of dyslipoproteinemia in Canadian adults. Can J Cardiol 1999;15:434-44.
13. Plasma lipid distributions in selected North American populations: the Lipid Research Clinics Program Prevalence Study. The Lipid Research Clinics Program Epidemiology Committee. Circulation 1979;60:427-39.
14. Bainton D, Miller NE, Bolton CH, et al. Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies. Br Heart J 1992;68:60-6.
15. Criqui MH, Heiss G, Cohn R, et al. Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med 1993;328:1220-5.
16. Hobbs CA, Wagner SG, Levinson SS. Relationships between triglycerides, lipoproteins, glucose and coronary artery disease. Clin Chim Acta 1995;238:59-70.
17. Hodis HN, Mack WJ. Triglyceride-rich lipoproteins and the progression of coronary artery disease. Curr Opin Lipidol 1995;6:209-14.
18. Hodis HN, Mack WJ, Azen SP, et al. Triglyceride-and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin. Circulation 1994;90:42-9.
19. Lamarche B, Despres JP, Moorjani S, Cantin B, Dagenais GR, Lupien PJ. Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Quebec Cardiovascular Study). Am J Cardiol 1995;75:1189-95.
20. Linden T, Bondjers G, Karlsson T, Wiklund O. Serum triglycerides and HDL cholesterol - major predictors of long-term survival after coronary surgery. Eur Heart J 1994;15:747-52.
21. Manninen V, Tenkanen L, Koskinen P, et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation 1992;85:37-45.
22. Sharrett AR, Patsch W, Sorlie PD, Heiss G, Bond MG, Davis CE. Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb 1994;14:1098-104.
23. Tenkanen L, Pietila K, Manninen V, Manttari M. The triglyceride issue revisited. Findings from the Helsinki Heart Study. Arch Intern Med 1994;154:2714-20.
24. Walldius G, Jungner I, Kolar W, Holme I, Steiner E. High cholesterol and triglyceride values in Swedish males and females: increased risk of fatal myocardial infarction. First report from the AMORIS (Apolipoprotein related Mortality RISk) study. Blood Press Suppl 1992;4:35-42.
25. NIH Consensus conference. Triglyceride, high-density lipoprotein, and coronary heart disease. NIH Consensus Development Panel on Triglyceride, High-Density Lipoprotein, and Coronary Heart Disease. JAMA 1993;269:505-10.
26. Havel RJ, Rapaport E. Management of primary hyperlipidemia [published erratum appears in N Engl J Med 1995;333:467]. N Engl J Med 1995;332:1491-8.
27. Moffatt RJ. Effects of cessation of smoking on serum lipids and high density lipoprotein-cholesterol. Atherosclerosis 1988;74:85-9.
28. Eliasson B, Attvall S, Taskinen MR, Smith U. Smoking cessation improves insulin sensitivity in healthy middle-aged men. Eur J Clin Invest 1997;27:450-6.
29. Sniderman AD, Cianflone K, Amer P, Summers LK, Frayn KN. The adipocyte, fatty acid trapping, and atherogenesis. Arterioscler Thromb Vase Biol 1998;18:147-51.
30. Hopkins PN, Hunt SC, Wu LL, Williams GH, Williams RR. Hypertension, dyslipidemia, and insulin resistance: links in a chain or spokes on a wheel? Curr Opin Lipidol 1996;7:241-53.